Thoratec Corporation

NASDAQ:THOR ISIN:US8851753074

2012年5月25日

概覽 | 新聞 | 多媒體 | 研究

Thoratec Corporation 公司資料

Thoratec Corporation (Thoratec) is a manufacturer of circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets products that are used by physicians and hospitals for cardiac assist, vascular and diagnostic applications. Thoratec operates in two business segments: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. Cardiac assist and vascular graft products represented 61% of Thoratec's product sales during the fiscal year ended December 29, 2007, (fiscal 2007). Point-of-care blood diagnostics test systems and services and incision products amounted to 39% of the Company's total product sales in 2007.

公司詳細

	主要部門	醫療器械

	支柱產業	醫療產品

	主頁	www.thoratec.com

Key Developments: Thoratec Corporation

	2月16日澳洲股市：不能指望快速復蘇 FEB 16, 2009 13:00 - Article Views: 9,327 上週五澳洲股市收市揚升，澳股在美國政府制定計劃幫助陷於困境的美國房屋業主的報告出台後的這一周以上漲結束。基本指數S&P/ASX200上漲44.8點，或1.27%，報3559.1點；綜合指數上漲38.2點，或1.1%，報3496.7點。奧巴馬政府現在試圖降低人們的期望，不要指望金融危機能快速解決，同時即將出台的盈利報告也可能會使市場下跌。